Beranda › Sindrom Distres Respirasi › Texas
Uji klinis Sindrom Distres Respirasi di Texas
14 studi untuk Sindrom Distres Respirasi mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Amarillo
- Research Site, Dallas
- Research Site, El Paso
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants
- Parkland Health and Hospital Systems, Dallas
Menerima peserta
0 Hours – 72 Hours · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07030270Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
- McGovern Medical School - UT Physicians Pulmonary Medicine - Texas Medical Center, Houston
- Baylor Scott & White Health, Temple
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05947955Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
- Christus Children's Hospital, San Antonio
Menerima pesertaFase 3
1 Hour – 24 Hours · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06776783JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06703073Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
- Baylor College of Medicine / St. Luke's Medical Center, Houston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06066502Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Dallas
- Direct Biologics Investigational Site, Fort Worth
- Direct Biologics Investigational Site, Houston
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT05354141Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- Houston Methodist Hospital, Houston
- Houston Methodist Research Institute, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2025 · NCT03642002Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
- Texas Children's Hospital Baylor College of Medicine, Houston
Menerima pesertaStudi observasional
Usia 0 hingga 21 · Semua jenis kelamin · Diperbarui 15 Nov 2024 · NCT06690801Clazakizumab vs. Placebo - COVID-19 Infection
- Houston Methodist Hospital, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2020 · NCT04494724Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.